Gapping up
In reaction to earnings/guidance:
- APXT +16.2% (provides guidance for AvePoint), AEO +6.1% (guides Q1 revs above consensus), CMPR +5.7% (guides MarQ revs above single analyst est), VSH +3.4% (issues upside Q1 guidance) UNH +2%, HROW +1.8%, BLK +1.6%, RAD +1.5%, TGNA +0.9% (guides Q1 revs above consensus),
M&A news:
- DELL +7.3% (DELL announces planned spin-off of 81% equity ownership of VMW), PPD +6.3% (to be acquired by Thermo Fisher Scientific (TMO), VMW +2.8% (DELL announces planned spin-off of 81% equity ownership of VMW),
Other news:
- KXIN +16.5% (announces approval by NASDAQ of Haitaoche acquisition)
- FSRV +9.7% (partners with custom PC retailer group Cybertron International, Inc. )
- IMUX +6.7% (announced interim data from Cohort 2 of its phase 2 EMPhASIS trial of IMU-838 in relapsing-remitting multiple sclerosis)
- MRNA +3.1% (met with Nexus Pharma re vaccine manufacturing, according to Reuters)
- DEH +3.1% (and Vicarious Surgical announce definitive business combination agreement )
- NVAX +2.7% (to participate in a Phase 2 trial which combines COVID vaccines)
- VLRS +2.1% (announces additional liquidity preservation initiatives, $100 mln of working capital relief), CMPS +1.4% (New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder)
- MLCO +1.2% (becomes first in Macau and the Philippines to receive esteemed third-party Responsible Gaming accreditation RG Check ), FGEN +1.1% (FDA has granted Rare Pediatric Disease Designation for the company's anti-CTGF antibody, pamrevlumab, for the treatment of patients with Duchenne muscular dystrophy),
Analyst comments:
- COIN +7.8% (initiated with a Buy at BTIG)
- AHH +4.8% (upgraded to Buy from Neutral at DA Davidson)
- BUD +4.2% (upgraded to Overweight from Equal Weight at Barclays)
- CRWD +2.5% (initiated with a Buy at Deutsche Bank)
- YI +1.9% (resumed with a Buy at Citigroup), HSY +1.7% (upgraded to Buy from Neutral at Goldman)
- CDLX +1.6% (upgraded to Overweight from Equal Weight at Wells Fargo), TDOC +1.5% (initiated with a Buy at Needham),